Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.
Johnson & Johnson subsidiary Janssen has launched an interactive educational website about diabetes for European healthcare professionals.
Shareholders of Belgian drug maker Movetis have put up nearly all of their shares for...
British drug maker Shire will acquire Belgian drug maker Movetis for $567 million, Movetis said....